Table 2.
Year | Country | Information sources | Main areas covered in the country-level GARP report | |||||||||
Demographics | Politic context | Economic context | Health systems setting | Disease burden | Antibiotic use | Drug regulation and supply chain | Other | |||||
Human | Animal | Human | Animal | |||||||||
2010 | Vietnam | Documentary review | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
2011 | India | Literature review | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Interventions to be considered | |||
2011 | Kenya | Documentary review | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
2011 | South Africa | Documentary review | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
2014 | Nepal | Literature review | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
2015 | Mozambique | Literature review, expert opinion | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
2015 | Tanzania | Documentary review | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
2015 | Uganda | Literature review, interviews | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
2017 | Zimbabwe | Literature review, interviews | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | AMR in agriculture | ||
2018 | Bangladesh | Documentary review, literature review | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Surveillance, requirements in establishing antimicrobial stewardship (AMS) (human resources, education, investment) | ||
2018 | Pakistan | Literature review, interviews | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | Drug accessibility, AMS and interventions | |||
No report available | Seychelles | |||||||||||
Laos | ||||||||||||
Namibia | ||||||||||||
Nigeria |
AMR, antimicrobial resistance; GARP, Global Antibiotic Resistance Partnership.